The global blood screening market is booming, projected to reach $5.76 billion by 2033, driven by rising infectious disease prevalence, technological advancements (NGS, ELISA), and stringent regulations. Explore market trends, key players (Becton Dickinson, Roche, Thermo Fisher), and regional growth in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.